J

Johnson & Johnson

Makes prescription drugs and medical devices

Senior Director - Immunology-AI Systems

Corporate StrategyConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An advanced degree (PhD, MD, PharmD, MS, or equivalent experience) in computer science, AI/ML, engineering, biomedical sciences, computational biology, applied mathematics, data science, or a related scientific or technical discipline is required.
  • A minimum of 10 years of post-academic industry or equivalent experience, including leadership of complex data, digital, AI, or technology-enabled life sciences initiatives, is required.
  • Demonstrated experience defining strategy and translating it into a prioritized roadmap and coordinated execution plan across complex multistakeholder ecosystems is required.
  • Strong technical fluency in AI/ML, data engineering, data products, analytics platforms, knowledge representation, and the lifecycle required to move solutions from prototype to scaled use is required.
  • Experience working with complex, high-dimensional biomedical data, such as omics, imaging, translational, clinical trial, biomarker, competitive intelligence, and real-world data, is required.
  • Proven ability to lead through influence in a matrixed organization in the pharmaceutical industry, align senior stakeholders, resolve ambiguity, and drive decisions across organizational boundaries is required.
  • Experience establishing governance, operating models, portfolio management practices, and value-tracking mechanisms for AI, data, digital, or technology portfolios in the pharmaceutical R&D setting is required.
  • Strong people leadership and talent-development experience is required.
  • The role requires executive communication, strategic thinking, synthesis, and decision-framing skills.

Responsibilities

  • Define and maintain the Immunology AI strategy, translating therapeutic-area priorities and pipeline needs into a clear multi-year roadmap of AI-enabled capabilities, data products, and solutions.
  • Lead strategic portfolio planning for Immunology AI, including opportunity identification, value framing, prioritization, sequencing, investment choices, dependencies, and resource alignment.
  • Create an integrated execution model across Immunology and enabling functions, with clear decision rights, accountable owners, milestones, risks, and measures of value.
  • Partner with Immunology scientific and development leaders to identify high-impact solutions across discovery, translational research, clinical development, biomarkers, evidence generation, and portfolio decision-making.
  • Provide technical leadership and informed challenges on AI solution design, data readiness, model suitability, validation, scalability, interoperability, and responsible use.
  • Orchestrate alignment and delivery across DDSAI functions, including Data Solutions & Platforms, Data Products & Governance, Master Data Governance, Knowledge Management, AI/ML Digital Health, RWE, Population Analytics & Insights, and External Innovation, as well as J&J Technology, Immunology TA, Global Development, and Global Regulatory Affairs; resolve cross-functional dependencies that could limit delivery or adoption.
  • Ensure AI initiatives are supported by fit-for-purpose data foundations, including standardized and reusable Immunology data products, metadata, ontologies, knowledge graphs, catalogs, and appropriate access pathways.
  • Establish portfolio governance and stage-gate decision processes that support rapid experimentation while creating a disciplined path to production, scale, operations, and lifecycle management.
  • Define success measures for the AI portfolio, including scientific and business outcomes, user adoption, time or quality improvements, scalability, reuse, and return on investment.
  • Drive adoption and organizational change by engaging end users early, embedding AI capabilities into scientific and development workflows, and championing AI and data literacy across Immunology by developing and implementing a robust change management strategy.
  • Build strong internal and external partnerships to monitor emerging AI capabilities and determine where to build, buy, partner, or reuse enterprise solutions.
  • Lead, develop, and retain a high-performing team with strengths spanning AI strategy, technical product leadership, data products, program execution, and stakeholder engagement.
  • Represent the Immunology AI strategy with senior R&D and enterprise stakeholders, communicating progress, choices, risks, and value in a clear and decision-oriented manner.

Desired Qualifications

  • Experience in life sciences, healthcare, pharmaceuticals, biotechnology, or medical technology; Immunology R&D experience is strongly preferred.
  • Experience leading enterprise or therapeutic-area AI strategy and execution across discovery and development workflows.
  • Experience with technical product management, agile delivery, change management, and scaled adoption of AI-enabled products.
  • Understanding of responsible AI, model validation, data privacy, security, regulatory expectations, and risk management in a biomedical environment.
  • Familiarity with enterprise data and metadata standards and frameworks, such as CDISC, GA4GH, FHIR, and NCI Thesaurus, and with ontologies, knowledge graphs, and data catalogs.
  • Demonstrated ability to evaluate build-versus-buy-versus-partner decisions and manage strategic technology or external innovation partnerships.

About the Company

Johnson & Johnson

Makes prescription drugs and medical devices

Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.

Company size
10,001+
Company stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886

Recently Posted Jobs

Explore more opportunities at Johnson & Johnson

See more jobs